Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations

被引:48
作者
Stokowski, RP [1 ]
Cox, DR [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
关键词
D O I
10.1086/302812
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Despite intense study of the neurofibromatosis type 2 (NF2) tumor-suppressor protein merlin, the biological properties and tumor-suppressor functions of merlin are still largely unknown. In this study, we examined the molecular activities of NF2-causing mutant merlin proteins in transfected mammalian cells, to elucidate the merlin properties that are critical for tumor-suppressor function. Most important, we found that 80% of the merlin mutants studied significantly altered cell adhesion, causing cells to detach from the substratum. This finding implies a function for merlin in regulating cell-matrix attachment, and changes in cell adhesion caused by mutant protein expression may be an initial step in the pathogenesis of NF2. In addition, five different mutations in merlin caused a significant increase in detergent solubility of merlin compared to wild type, indicating a decreased ability to interact with the cytoskeleton. Although not correlated to the cell-adhesion phenotype, four missense mutations decreased the binding of merlin to the ERM-interacting protein EBP-50, implicating this interaction in merlin inhibition of cell growth. Last, we found that some NF2 point mutations in merlin most closely resembled gain-of-function alleles in their cellular phenotype, which suggests that mutant NF2 alleles may not always act in a loss-of-function manner, as had been assumed, but may include a spectrum of allelic types with different phenotypic effects on the function of the protein. In aggregate, these cellular phenotypes provide a useful assay for identifying the functional domains and molecular partners necessary for merlin tumor-suppressor activity.
引用
收藏
页码:873 / 891
页数:19
相关论文
共 65 条
[1]   EZRIN CONTAINS CYTOSKELETON AND MEMBRANE-BINDING DOMAINS ACCOUNTING FOR ITS PROPOSED ROLE AS A MEMBRANE-CYTOSKELETAL LINKER [J].
ALGRAIN, M ;
TURUNEN, O ;
VAHERI, A ;
LOUVARD, D ;
ARPIN, M .
JOURNAL OF CELL BIOLOGY, 1993, 120 (01) :129-139
[2]   ALTERNATIVE SPLICING OF THE NF2 GENE AND ITS MUTATION ANALYSIS OF BREAST AND COLORECTAL CANCERS [J].
ARAKAWA, H ;
HAYASHI, N ;
NAGASE, H ;
OGAWA, M ;
NAKAMURA, Y .
HUMAN MOLECULAR GENETICS, 1994, 3 (04) :565-568
[3]   Mapping of ezrin dimerization using yeast two-hybrid screening [J].
Bhartur, SG ;
Goldenring, JR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (03) :874-877
[4]   GERMLINE MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 TUMOR-SUPPRESSOR GENE [J].
BOURN, D ;
CARTER, SA ;
MASON, S ;
EVANS, DGR ;
STRACHAN, T .
HUMAN MOLECULAR GENETICS, 1994, 3 (05) :813-816
[5]   Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane [J].
Deguen, B ;
Mérel, P ;
Goutebroze, L ;
Giovannini, M ;
Reggio, H ;
Arpin, M ;
Thomas, G .
HUMAN MOLECULAR GENETICS, 1998, 7 (02) :217-226
[6]  
DENBAKKER MA, 1995, ONCOGENE, V10, P757
[7]  
DENBAKKER MA, 1995, AM J PATHOL, V147, P1339
[8]   IDENTIFICATION OF DROSOPHILA CYTOSKELETAL PROTEINS BY INDUCTION OF ABNORMAL-CELL SHAPE IN FISSION YEAST [J].
EDWARDS, KA ;
MONTAGUE, RA ;
SHEPARD, S ;
EDGAR, BA ;
ERIKSON, RL ;
KIEHART, DP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4589-4593
[9]   DIAGNOSTIC ISSUES IN A FAMILY WITH LATE-ONSET TYPE-2 NEUROFIBROMATOSIS [J].
EVANS, DGR ;
BOURN, D ;
WALLACE, A ;
RAMSDEN, RT ;
MITCHELL, JD ;
STRACHAN, T .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (06) :470-474
[10]  
EVANS DGR, 1992, Q J MED, V84, P603